Literature DB >> 16724071

Homocysteine and risk of developing hypertension in men.

T S Bowman1, J M Gaziano, M J Stampfer, H D Sesso.   

Abstract

In cross-sectional studies, elevated homocysteine levels are associated with higher blood pressure, but it remains unclear whether plasma homocysteine is a risk factor for hypertension. In a prospective nested case-control study, participants who developed hypertension (n=396) had significantly higher levels of baseline plasma homocysteine (12.6 mol/l) than matched controls (11.8 mol/l, P=0.03); compared to those in the lowest quintile, those in the highest quintile had a crude relative risk (RR) of 1.56 (95% confidence interval (CI), 0.98-2.48; P for trend=0.10) and a multivariable RR of 1.63 (95% CI, 0.97-2.74; P for trend=0.13). Higher plasma homocysteine levels at baseline were associated with an increased but non-significant risk of incident hypertension that was minimally affected by multivariable adjustment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724071     DOI: 10.1038/sj.jhh.1002052

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  15 in total

Review 1.  Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension.

Authors:  Sudhakar Veeranki; Siva K Gandhapudi; Suresh C Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2016-04-28       Impact factor: 2.273

2.  Insulin resistance explains the relationship between novel cardiovascular risk factors and hypertension. The Telde Study.

Authors:  A M Wägner; J C Wiebe; M Boronat; P Saavedra; D Marrero; F Varillas; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

3.  Uric acid and insulin sensitivity and risk of incident hypertension.

Authors:  John P Forman; Hyon Choi; Gary C Curhan
Journal:  Arch Intern Med       Date:  2009-01-26

Review 4.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

5.  Evidence on the causal link between homocysteine and hypertension from a meta-analysis of 40 173 individuals implementing Mendelian randomization.

Authors:  Liwan Fu; Ya-Nan Li; Dongmei Luo; Shufang Deng; Baihui Wu; Yue-Qing Hu
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

6.  Relationship between homocysteine and hypertension: New data add to the debate.

Authors:  Jamario Skeete; Donald J DiPette
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-24       Impact factor: 3.738

7.  Interactions of homocysteine and conventional predisposing factors on hypertension in Chinese adults.

Authors:  Boyi Yang; Shujun Fan; Xueyuan Zhi; Jing He; Ping Ma; Luyang Yu; Quanmei Zheng; Guifan Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-24       Impact factor: 3.738

8.  C677T MTHFR Gene Polymorphism is Contributing Factor in Development of Renal Impairment in Young Hypertensive Patients.

Authors:  Hanaa H Elsaid; Khaled A El-Hefnawy; Saffaa M Elalawi
Journal:  Indian J Clin Biochem       Date:  2020-05-14

9.  Association between plasma homocysteine and hypertension: Results from a cross-sectional and longitudinal analysis in Beijing's adult population from 2012 to 2017.

Authors:  Li-Xin Tao; Kun Yang; Jie Wu; Gehendra Mahara; Jie Zhang; Jing-Bo Zhang; Zhao Ping; Xiuhua Guo
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-26       Impact factor: 3.738

10.  Investigation of homocysteine-pathway-related variants in essential hypertension.

Authors:  Javed Y Fowdar; Marta V Lason; Attila L Szvetko; Rodney A Lea; Lyn R Griffiths
Journal:  Int J Hypertens       Date:  2012-10-23       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.